Compare MLSS & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | MNDO |
|---|---|---|
| Founded | 1989 | 1995 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1M | 20.0M |
| IPO Year | 1996 | 2000 |
| Metric | MLSS | MNDO |
|---|---|---|
| Price | $0.37 | $0.91 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 515.3K | 47.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 20.95% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,973,982.00 | N/A |
| Revenue This Year | $12.64 | N/A |
| Revenue Next Year | $8.99 | N/A |
| P/E Ratio | ★ N/A | $8.57 |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $0.85 |
| 52 Week High | $1.01 | $1.50 |
| Indicator | MLSS | MNDO |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 34.06 |
| Support Level | $0.25 | $0.89 |
| Resistance Level | $0.42 | $1.24 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 41.31 | 30.62 |
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.